Exchange: NASDAQ·Updated 11:28 AM EDT
DWTX logo

DWTX Dogwood Therapeutics Inc.

$2.59
$0.11
(4.43%)
Today
Reported EarningsAug 13
Mkt Cap$84.3M
Vol15,621.00

About DWTX

Dogwood Therapeutics, Inc. is a development-stage biotechnology company, which engages in developing therapeutics for pain and fatigue illness. Its product includes Halneuron. It focuses on antiviral therapies IMC-1 and IMC-2 to treat diseases associated with a viral triggered abnormal immune response such as Long-COVID and fibromyalgia. The company was founded on February 28, 2012 is headquartered in Alpharetta, GA.
54

Neutral Sentiment

How do you feel about DWTX?

Advertisement|Remove ads.